Oxford Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-24,247
| Closed | -$412K | – | 2066 |
|
|
2018
Q3 | $412K | Buy |
+24,247
| New | +$412K | 0.01% | 1386 |
|
|
2017
Q4 | – | Sell |
-63,040
| Closed | -$943K | – | 1843 |
|
|
2017
Q3 | $943K | Buy |
+63,040
| New | +$943K | 0.02% | 959 |
|
|
2016
Q3 | – | Sell |
-77,442
| Closed | -$448K | – | 851 |
|
|
2016
Q2 | $448K | Sell |
77,442
-335,702
| -81% | -$1.94M | 0.01% | 600 |
|
|
2016
Q1 | $2.5M | Sell |
413,144
-28,140
| -6% | -$170K | 0.07% | 321 |
|
|
2015
Q4 | $4.05M | Buy |
441,284
+221,120
| +100% | +$2.03M | 0.1% | 231 |
|
|
2015
Q3 | $1.24M | Buy |
220,164
+42,856
| +24% | +$242K | 0.04% | 371 |
|
|
2015
Q2 | $1.97M | Buy |
177,308
+40,616
| +30% | +$450K | 0.05% | 349 |
|
|
2015
Q1 | $2.14M | Sell |
136,692
-92,770
| -40% | -$1.45M | 0.05% | 349 |
|
|
2014
Q4 | $3.41M | Buy |
229,462
+99,035
| +76% | +$1.47M | 0.08% | 265 |
|
|
2014
Q3 | $1.41M | Buy |
+130,427
| New | +$1.41M | 0.03% | 425 |
|
|
2013
Q3 | – | Sell |
-79,432
| Closed | -$620K | – | 886 |
|
|
2013
Q2 | $620K | Buy |
+79,432
| New | +$620K | 0.02% | 663 |
|